SCHEMBL19644274

SCHEMBL19644274

CON(C)C(=O)C(N)CCCNC(=N)N

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
NPY4R P50391 11/20 0.37
NPY1R P25929 6/20 0.37
DPP7 Q9UHL4 2/20 0.36
OTC P00480 1/20 0.36
NPY2R P49146 4/20 0.35
NPY5R Q15761 4/20 0.35
GNAI3 P08754 1/20 0.33
GNAO1 P09471 1/20 0.33
GNAI1 P63096 1/20 0.33
ALOX15 P16050 1/20 0.33
DDAH1 O94760 1/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL475812 1.00 NOS3 (0.38) NOS3NOS1NOS2NPY4RNPY1R
SCHEMBL27382578 0.84 NOS3 (0.41) NOS3NOS1NOS2NPY4RNPY1R
SCHEMBL9952947 0.84 NOS3 (0.41) NOS3NOS1NOS2NPY4RNPY1R
Hydrochloric Acid SCHEMBL8063762 0.83 NOS3 (0.41) NOS3NOS1NOS2NPY4RNPY1R
SCHEMBL2172217 0.80 NPY4R (0.45) NOS3NOS1NOS2NPY4RNPY1R
SCHEMBL42488 0.80 NPY4R (0.45) NOS3NOS1NOS2NPY4RNPY1R
SCHEMBL157856 0.80 NPY4R (0.45) NOS3NOS1NOS2NPY4RNPY1R
SCHEMBL18796571 0.79 DPP7 (0.41) NOS3NOS1NOS2NPY4RNPY1R
Hydrochloric Acid SCHEMBL2762373 0.78 NPY4R (0.44) NOS3NOS1NOS2NPY4RNPY1R
Hydrochloric Acid SCHEMBL940539 0.78 NPY4R (0.44) NOS3NOS1NOS2NPY4RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118556068-A CD44 binding peptide reagents and methods 密歇根大学董事会 2024-08-27 CN disclosed
CN-110831634-B Glypican-3 peptide reagents and methods 密歇根大学董事会 2024-07-02 CN disclosed
CN-112546244-B Fibroblast growth factor receptor 2 specific peptide reagents and methods 密执安州立大学董事会 2023-07-04 CN disclosed
CN-108697756-B HER2 peptide reagents and methods 密歇根大学董事会 2022-05-27 CN disclosed
CN-114269367-A Therapeutic peptides 科巴公司 2022-04-01 CN disclosed
CN-113518784-A Therapeutic peptides 科巴公司 2021-10-19 CN disclosed
CN-107073065-B Peptide reagents and methods for detection and targeting of dysplasia, early stage cancer, and cancer 密歇根大学董事会 2021-07-02 CN disclosed
CN-112546244-A Fibroblast growth factor receptor2 specific peptide reagents and methods 密执安州立大学董事会 2021-03-26 CN disclosed
CN-111107881-A Fibroblast growth factor receptor2 specific peptide reagents and methods 密执安州立大学董事会 2020-05-05 CN disclosed
CN-110831634-A Glypican-3 peptide reagents and methods 密歇根大学董事会 2020-02-21 CN disclosed
CN-105324397-B Insulin-incretin conjugates 印第安纳大学研究及科技有限公司 2020-01-14 CN disclosed
EP-3463429-A1 INSULIN RECEPTOR PARTIAL AGONISTS AND GLP-1 ANALOGUES Merck Sharp & Dohme Corp. (US) 2019-04-10 EP disclosed
WO-2017205191-A1 INSULIN RECEPTOR PARTIAL AGONISTS AND GLP-1 ANALOGUES MERCK SHARP & DOHME CORP. (US) 2017-11-30 WO disclosed